XGENE BIOTECHNOLOGY COMPANY LIMITED
Update：2025/12/24
Industries
Main Industry
Health Care
Main Product/Service
Xgene’s key products are clinical-stage analgesic candidates, including oral dual‑mechanism conjugates and topical gels, designed to enhance efficacy and safety through multimodal mechanisms and high target specificity.
Founded Year
2015
Unified Business No.
42836798
Status
Active
Number of Employees
0
Total Paid-in
Capital
100,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Xgene Pharmaceutical Inc. is an innovative biotech company focused on neurological disorders and pain management, using proprietary linker technology to develop dual‑acting prodrugs aimed at safer and more effective next‑generation analgesic therapies.
